<DOC>
	<DOCNO>NCT01539044</DOCNO>
	<brief_summary>Muscle relaxation use rocuronium infusion sugammadex reversal hypothetically provide good quality muscle relaxation rapid recovery anaesthesia compare intermittent bolus rocuronium muscle relaxant reverse neostigmine . 50 patient undergoing major laparotomy surgery predict surgical time 90 minute randomise 2 treatment arm : CI-sugammadex &amp; IB-Neostigmine . After bolus rocuronium give induction , patient CI-Sugammadex arm start rocuronium infusion immediately rate adjust accord target PTC 1-2 . Patients randomise IB-Neostigmine give bolus rocuronium reappearance TOFC 2 . At end surgery , subject reverse either sugammadex neostigmine different depth block , ie PTC 1-2 TOFC 2 respectively . Quality intraoperative relaxation effectiveness reversal 2 technique , CI-Sugammadex IB-Neostigmine compare respect : 1 . Time full reversal ( T4/T1 [ TOF ] ratio ≥ 0.9 ) neuromuscular blockade : - PTC 1-2 CI-Sugammadex group - TOFC ≥2 IB-Neostigmine group 2 . Incidence residual neuromuscular blockade ( T4/T1 ratio &lt; 0.9 ) 3 . Improved quality intraoperative neuromuscular relaxation maintain profound neuromuscular blockade , reflect reduced incidence intraoperative event high VAS grade relaxation quality surgeon</brief_summary>
	<brief_title>Optimal Relaxation Technique Laparotomies With Rocuronium Infusion Followed Sugammadex Reversal</brief_title>
	<detailed_description>Epidural establish induction standard balance general anesthesia . After epidural , randomize 2 group , CI-Sugammadex group IB-Neostigmine group . Intra operative analgesia achieve epidural bolus . Adjuvant drug administer per routine clinical practice use compare group . For patient randomized CI-Sugammadex group , intravenous infusion 0.3 mg/kg/hr ( organon product insert ) administer 30 minute intubation dose return PTC , whichever come first . Then , infusion rate titrate accord PTC ( target keep PTC 1 2 ) . Infusion rate increase reduce rate 0.1 mg/kg/hr PTC &gt; &lt; 1-2 adequate muscle relaxation maintain throughout surgery . A dose Sugammadex ( 4 mg/kg ) administer end surgery ( last stitch ) . For patient allocated IB-Neostigmine group , bolus Rocuronium dose 10mg administered reappearance TOFC &gt; 2 depth neuromuscular blockade maintain TOFC 1-2 . At end surgery , dose Neostigmine ( 50mcg/kg ) give reappearance TOFC 2 . Rescue boluses Rocuronium give clinically indicated regardless depth neuromuscular block appear TOF-watch . The patient exclude his/her epidural fail function full dose opioid need intra operatively analgesia . Patients whose surgery end return first PTC 1-2 CI-Sugammadex group TOFC 2 IB-Neostigmine group also exclude drop out Central core temperature ( measure nasopharyngeal probe ) maintain 35°C throughout surgery . Heart rate , oxygen saturation , blood pressure , end-tidal concentration volatile agent end-tidal carbon dioxide concentration monitor throughout surgery . After operation , patient monitor peri anesthetic period post anesthetic care unit ( PACU ) least 60min post-anesthetic monitoring include post-operative visit safety assessor follow-up surveillance 24H surgery . Time full reversal ( T4/T1 ratio ≥ 0.9 ) neuromuscular blockade secondary variable document . In PACU , assess clinical sign adequate neuromuscular recovery T4/T1 ratio ( best 3 reading record ) detect incidence residual recurrence neuromuscular blockade . All patient ' oxygen saturation , blood pressure , heart rate respiratory rate monitor 24H surgery adequate analgesia provide . Surgeons blind treatment arm give visual analogue scale ( VAS ) ass quality relaxation surgery immediately ungowned end surgery . All subject assess adverse event serious adverse event ( Itching &amp; erythematous reaction site injection and/or generalize histaminoid reaction example bronchospasm &amp; cardiovascular change ) . Patients , surgeon , post-operative assessor nurse ward blind group allocation . The non-blinded attending anesthetist , responsible individual patient ' relaxation technique , vested interest reversal agent outcome trial , participate postoperative clinical assessment , data entry , statistical analysis .</detailed_description>
	<mesh_term>Muscle Hypotonia</mesh_term>
	<mesh_term>Atropine</mesh_term>
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<criteria>Patient age 18 75 year old ; ASA I III ; Elective SemiEmergency Laparotomy general anaesthesia need tracheal intubation muscle relaxation ; Severe renal impairment ( CrCL &lt; 30 ml/ min ) ; Severe hepatic impairment ; BMI &gt; 30 kg m2 ; Known suspect neuromuscular disorder ; Allergies narcotic , muscle relaxant , benzodiazepine medication use general anesthesia ; Hypersensitivity active substance excipients Patient difficult intubation anticipate physical examination ; Patient contraindicate epidural analgesia ; Patient aminoglycoside antibiotic , anticonvulsant magnesium , interfere action rocuronium ; Female patient pregnant , breastfeeding , child bear potential use adequate contraception ; Patient poor GCS mental derangement unable give consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>reversal</keyword>
	<keyword>muscle relaxant</keyword>
	<keyword>sugammadex</keyword>
</DOC>